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Papillomavirus E1 and E2 proteins are essential for the initiation of viral DNA replication. We have now analyzed the
interaction of E1 and E2 of human papillomavirus type 33, which is associated with cervical carcinoma. When synthesized
in insect cells using the baculovirus expression system, the E1 and E2 proteins interacted efficiently at 47. A monoclonal
antibody recognizing E1 amino acids 584–600 inhibited the binding of E2 and vice versa, indicating that these amino acids
are involved in E2 binding. To confirm this result, a mutational analysis of E1 was performed. The E2 binding activity of E1
deletion and point mutant proteins was assayed using glutathione S-transferase E1 fusion proteins and in vitro translated
proteins. At 47, the C-terminal portion of E1 including amino acids 312–644 was sufficient for E2 binding. Introduction of
C-terminal deletions or a point mutation at position 586 (Pro r Glu) resulted in the loss of the E2 binding activity. A second
more N-terminally located binding domain (E1 amino acids 312–450) became active when the assays were performed at
227. The monoclonal antibody still inhibited E2 binding at this temperature, indicating that both E2 binding domains are
engaged in the context of the full-length protein. q 1996 Academic Press, Inc.
INTRODUCTION open reading frame as an essential constituent for the
maintenance of episomal BPV DNA (Sarver et al., 1984;
Papillomaviruses are small nonenveloped viruses with Lusky and Botchan, 1985, 1986; Groff and Lancaster,
a circular double-stranded DNA genome of approxi- 1986). The E1 protein of BPV-1 has hence been exten-
mately 7800 bp. They infect epithelial cells of the skin sively characterized. It has been shown to contain an
and the mucosa, inducing local hyperproliferative le- intrinsic NTPase, a DNA helicase, and a specific DNA
sions, like papillomas and intraepithelial neoplasias. The binding activity (Ustav et al., 1991; Wilson and Ludes
viral life cycle can be divided into three stages. Following Meyers, 1991; Yang et al., 1991, 1993; Thorner et al.,
infection of basal stem cells the viral genome is estab- 1993; Seo et al., 1993b).
lished as 20 to 50 episomal copies per cell. In latent Mutations in the E2 gene showed a much more com-
infections the viral genome is replicated as an episome plex phenotype, affecting both the expression of viral
in an apparently cell cycle-dependent manner, resulting genes and DNA replication (Lusky and Botchan, 1985;
in a constant copy number. Only in differentiated nondi- Rabson et al., 1986; Groff and Lancaster, 1986). Transient
viding cells is the amplification of viral DNA and the replication assays using BPV genes under the control of
production of virus particles observed (Chow and Broker, heterologous promoters transfected into cell lines con-
1994). The switch from cell cycle-dependent to cell cycle- taining plasmids carrying the BPV origin of replication
independent replication makes papillomaviruses a very demonstrated that E2 is essential for BPV DNA replica-
interesting system for the study of mammalian DNA repli- tion (Ustav and Stenlund, 1991). The E2 open reading
cation. frame encodes several proteins, a full-length E2, and two
Bovine papillomavirus type 1 (BPV-1) is the only repre- N-terminally truncated forms. Each of them binds to a
sentative among the family of papillomaviruses that is consensus sequence (ACC(N)6GGT), thereby regulating
able to infect mouse cell lines (e.g., C127 and NIH 3T3), viral transcription (Ham et al., 1991). Only the full-length
resulting in transformed cells carrying stably replicating E2 protein supports viral replication (Ustav and Stenlund,
episomal copies of BPV DNA (Dvoretzky et al., 1980). 1991).
Stable BPV episomes were also obtained after transfec- A cell-free system using crude cellular extracts in addi-
tion of these cells with BPV DNA (Law et al., 1981). This tion to viral proteins has been used to demonstrate that
opened the way to the study of BPV replication by muta- E1 is essential for BPV DNA replication (Yang et al.,
tional analysis and allowed the identification of the E1 1991). High concentrations of the E1 protein alone sus-
tained BPV DNA replication at a low level, but the pres-
ence of E2 greatly enhanced DNA replication. E2 was1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 6131-392359. shown to be indispensable at limiting E1 concentrations.
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E2 forms a heteromeric complex with E1 in solution cervical carcinoma (Cole and Streeck, 1986), were syn-
thesized using bacterial and eukaryotic expression sys-(Mohr et al., 1990; Lusky and Fontane, 1991; Blitz and
Laimins, 1991), strongly stimulating the specific DNA tems and their interaction was analyzed in vitro. Here
we report the mapping of E1 domains responsible forbinding activity of E1 as well as the origin-specific un-
winding reaction catalyzed by E1 (Yang et al., 1991; Lusky interaction with E2 in solution at 4 and 227.
et al., 1993; Seo et al., 1993a). This suggests that E1
plays a key role in ori recognition and that E2 serves to MATERIALS AND METHODS
augment its activity. The minimal BPV origin of replication
Construction of plasmids
contains an E1 binding site, an 18-bp imperfect palin-
drome, in addition to an AT-rich region and half an E2 All manipulations with DNA were carried out following
standard protocols (Maniatis et al., 1982). Plasmids car-binding site or one low-affinity E2 binding site (Yang et
al., 1991; Ustav et al., 1993). rying truncated E1 or E2 genes are designated according
to the first and last E1 or E2 codon, respectively, stillMuch less is known about the role and biochemical
properties of the E1 and E2 proteins encoded by human present in the mutant gene. The vector/gene junctions
of all constructs were sequenced to verify the correctpapillomaviruses (HPV). The best studied virus is HPV-
11, the most frequent cause of laryngeal papillomas orientation of the insert. pG33E1-441/641 was con-
structed by fusing an EcoRV/BglII fragment of HPV-33which is also commonly associated with benign genital
warts (Dartmann et al., 1986). Recently, a cell-free replica- (nt 2200–2800) in frame to the glutathione S-transferase
(GST) gene of pGEX3X (Pharmacia).tion system was developed for HPV-11 (Kuo et al., 1994).
As for BPV-1 replication, a strict dependence on the viral Construction of deletion mutants for epitope mapping
via polymerase chain reaction (PCR) (Saiki et al., 1988)ori and the E1 and E2 proteins was observed. However,
some remarkable differences to the BPV-1 replication with pG33E1-441/641 as template was carried out as
described before (Volpers et al., 1993). Briefly, PCRs withsystem were found. An intact E2 binding site was abso-
lutely required for HPV-11 replication in vitro, as pre- a 5* primer hybridizing to pGEX3X vector DNA at its
unique Csp45I site and various 3* primers were per-viously observed in vivo (Chiang et al., 1992; Russell and
Botchan, 1995). Furthermore, E1 displayed only a weak formed to obtain deletions from the carboxy-terminus.
The 5* primer had the sequence 5*-GCTGAAAATGTT-DNA binding activity, and the E1 binding site was dis-
pensable for replication using transient replication CGAAGATC-3*. All 3* primers were complementary to
successive parts of the E1 fragment present in pG33E1-assays (Lu et al., 1993). These results suggest that the
HPV-11 E2 protein, rather than E1, is the primary ori 441/641 and contained a nonhybridizing ‘‘tail’’ carrying an
EcoRI restriction site. Deletions from the amino-terminusrecognition protein and that E2 targets E1 via complex
formation to the origin of replication (Kuo et al., 1994; were introduced by PCR using pG33E1-441/641 DNA as
template, a series of 5* primers, and a 3* primer hybridiz-Chow and Broker, 1994).
At present, the detailed analysis of the E1/E2 interac- ing to pGEX3X DNA at its unique AatII site (5*-GCCACC-
TGACGTCTAAGAAACCA-3*). Each of the 5* primers pos-tion is limited to BPV-1. It has yielded conflicting results
concerning the E1 domain responsible for interaction sessed a BamHI restriction sequence at its 5* end which
did not hybridize with the E1 sequence. PCR productswith E2. Using proteins purified from insect Sf9 cells it
has been shown that E1 binds preferentially to non- or were double-digested with Csp45I/EcoRI or BamHI/AatII,
respectively, and ligated with pGEX3X which had beenunderphosphorylated species of E2 and that the C-termi-
nus of E1 is sufficient for interaction when assayed at 47 cleaved correspondingly.
pG33E2-17/250 was constructed by fusing a filled-in(Lusky and Fontane, 1991). Recently, these results were
confirmed using purified E2 protein and truncated E1 BglII/StyI fragment (nt 2797–3498) in frame to the GST
gene of pGEX3X. The full-length HPV-33 E1 gene wasproteins synthesized in vitro (Thorner et al., 1993). In
contrast, it has been reported that the C-terminus is not amplified from a PvuII fragment of HPV-33 (nt 721–4450)
cloned into pUC18 (pPv1Pv2) via PCR using oligonu-required for complex formation with E2 at room tempera-
ture or 307 (Thorner et al., 1993; Benson and Howley, cleotides 5* - AAATGGATCCATGGCCGATCCTGAAG - 3*
(ON33E1-1-5*) and 5*-AGAATTCCTGTGGTGTCTGCA-1995).
No detailed mutagenesis studies have as yet been GGTC-3* (ON33E4-39-3*) as primers. Boldface and italic
letters highlight the restriction enzyme recognition sitesperformed for HPV-encoded E1 even though an interac-
tion with E2 in solution has been demonstrated (Bream introduced and the E1 start codon, respectively. The am-
plified fragment was cut with HindIII (HPV-33 nt 3039),et al., 1993; Storey et al., 1995; Hibma et al., 1995). Be-
cause of the differences observed regarding the require- filled-in with the Klenow fragment of DNA polymerase
I, recut with BamHI, and cloned into BamHI/SmaI-cutments for replication of HPV-11 and BPV-1 DNA, respec-
tively, we initiated a detailed study to obtain more in- pSP64(polyA) (Promega) and pGEX4T-1 (Pharmacia) to
obtain pSP33E1-1/644 and pG33E1-1/644, respectively.sights into the domain structure of HPV-encoded E1. The
E1 and E2 proteins of HPV-33, which is associated with pSP33E1-75/644, -150/644, and -312/644 were con-
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structed similarly with forward primers annealing to HPV- vitrogen) to obtain pVL33E1. To construct pVL33E2, a
filled-in NcoI/NdeI fragment (nt 2748–4064) was cloned33 E1 nucleotides 1101–1119 (ON33E1-75-5*), 1326 –
1343 (ON33E1-150-5*), and 1812–1831 (ON33E1-312-5*), into the SmaI site of pVL1392 (Invitrogen). The transfer
vectors were used to transfect Sf9 cells together withrespectively. An ATG start codon was included in each
of the oligonucleotides. pSP33E1-1/520 and -1/450 were wild-type baculovirus (pVL33E1) or BaculoGold DNA
(pVL33E2) (PharMingen). The recombinant baculovirusesconstructed using the phosphorylated primers 5*-CGT-
TCCCGGGTCATATTGGCGTTACATCATCTA-3* and 5*- bac33E1 and bac33E2 obtained were plaque purified and
multiplied using standard protocols (Summers and Smith,GCACCCCGGGTCATAAAAATGCTGTAAATTCAATG-3*
as reverse and ON33E1-1-5* as forward primers, respec- 1987).
tively, for PCR. Boldface and underlined letters indicate
Purification of proteinsthe introduced SmaI site and the stop codon, respec-
tively. The fragments were cut with BamHI and cloned
Proteins synthesized in E. coli. Synthesis of GST fusion
into BamHI/SmaI-cut pSP64(polyA). pSP33E1-75/450
proteins was carried out in Escherichia coli DH5a exactly
and -75/520 were constructed by exchanging an NdeI/
as described except that the temperature was lowered
EcoRI fragment (HPV-33 nt 1949) from pSP33E1-75/644
to 277 just before induction with IPTG (Smith and John-
with NdeI/EcoRI fragments from pSP33E1-1/450 and -1/
son, 1988). The insoluble fractions of fusion proteins
520, respectively. pSP33E1-312/450 and -312/520 were
G33E1-441/641 and G33E2-17/250 were gel-purified as
constructed similarly starting with pG33E1-312/644. To
described (Volpers et al., 1993). Soluble GST fusion pro-
fuse the mutant HPV-33 E1 genes to the GST gene of
teins were purified by affinity chromatography on gluta-
pGEX4T-1, BamHI/EcoRI fragments were isolated from
thione–Sepharose following the vendor’s instruction
the different pSP33E1 constructs and cloned into BamHI/
(Pharmacia).
EcoRI-cut pGEX4T-1 to obtain pG33E1-75/644, -150/644,
Proteins expressed in insect cells. E1 and E2 proteins
-312/644, -1/520, -1/450, -75/520, -312/520, and -312/450.
were extracted after 3 days from Sf9 cells infected with
pG33E1-312/420 and -312/375 were constructed by PCR
the recombinant viruses at a multiplicity of 10. All buffers
amplification of E1 fragments using ON33E1-312-5* as a
contained aprotinin and leupeptin (10 mg/ml each). Cells
forward primer and oligonucleotides annealing to HPV-
were harvested (5 min, 800 g) and washed once with
33 nucleotides 2119–2138 and 1983–2003, respectively,
phosphate-buffered saline (PBS). All subsequent steps
as reverse primers. The reverse primers carried a stop
were carried out on ice. The cells were washed with
codon and an EcoRI recognition site as a nonhybridizable
buffer A (20 mM Tris–HCl, 10 mM KCl, 1.5 mM MgCl2 ,tail, each. The isolated fragments were cut with BamHI
10% glycerol, and 1 mM dithiothreitol (DTT), pH 7.5), re-
and EcoRI and ligated to correspondingly cut pGEX4T-1.
suspended in buffer A, and incubated on ice for 20 min.
pG33E1-1/206 and -1/358 were constructed by cutting
Cells were lysed in a dounce homogenizer (pestle A; 15
pG33E1-1/644 with StuI (HPV-33 nt 1497), XhoI and NdeI
strokes), and the nuclei were pelleted for 5 min at 2000
(nt 1950), and XhoI, respectively, and religating the vector
g. The pellet was resuspended in buffer B (20 mM Tris–
fragment after filling-in with the Klenow polymerase.
HCl, 300 mM NaCl, 0.25% Triton X-100, 10% glycerol, 1
pSP33E1- and pG33E1-1/644-P586E were constructed
mM DTT, pH 7.5) (2.5 ml/108 cells) and incubated on ice
using oligonucleotides 5*-CCCCGAATTCGATGAAAATG-
with shaking for 1 hr. The resulting supernatants were
GTAACCCA-3* and ON33E1-1-5* and 5*-AACCGAATT-
spun for 1 hr at 28,000 rpm and 47 in a SW 40 rotor.
CGAATGGATTTTTAAATTCAAA-3* and ON33E4-39-3*, re-
The supernatants, which contain the E1 or E2 proteins,
spectively, in two separate PCR reactions with pPv1Pv2
respectively, were used directly.
as template. The resulting two fragments were fused into
pUC18 via the newly generated EcoRI sites (boldface Monoclonal antibodies
letters) and subsequently transferred to pSP64(polyA)
and pGEX4T-1, respectively. This results in the mutation Mice (Balb/c) were immunized with 30 mg of G33E1-
441/641 and G33E2-17/250 purified by sodium dodecylof a proline residue at position 586 (CCA) to glutamic
acid (GAA). The exchange of a BamHI/NdeI fragment of sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE) (Volpers et al., 1993), respectively, in completepSP33E1-1/644-P586E for a BamHI/NdeI fragment from
pG33E1-75/644 and -312/644 resulted in pSP33E1-75/ Freund’s adjuvant, followed by three boosts with the
same antigen in incomplete Freund’s adjuvant, injected644-P586E and -312/644-P586E, respectively. pG33E1-
75/644-P586E was constructed by exchanging an XbaI/ intraperitoneally at 5- to 6-week intervals. Fusion of
spleen cells with myeloma cell X63Ag8.653 was per-XhoI from pG33E1-1/644-P586E for the same fragment in
pG33E1-75/644. formed as described (Galfre et al., 1977). G33E1-441/641
and G33E2-17/250 were used as antigens in ELISAs to
Recombinant baculoviruses screen for hybridoma cell lines secreting E1 (33E1-C1A)-
and E2-specific (33E2-Ste3) monoclonal antibodiesAn ApaLI/PstI fragment of HPV-33 (nt 854–3441) was
cloned into the SmaI and PstI sites of pVL1393 (In- (MAbs), respectively. One hybridoma cell line (GST-A)
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secreting a MAb specific for the GST portion was also were subsequently washed with PBS (800 g, 2 min) and
equilibrated in buffer B. Four milliliters of E2-containingisolated using denatured GST as antigen in ELISAs.
nuclear extract was then added to the beads and incu-
In vitro translation bated in a shaker for 12 (47) or 3 hr (227), respectively. The
beads were washed with 10 ml of buffer B, transferred toProteins were synthesized and labeled in vitro with
a column, and washed again with 2 ml of PBS. Bound[35S]methionine (1000 Ci/mmol) using the TNT coupled
proteins were eluted in 50 mM Tris, pH 8.0, supple-rabbit reticulocyte extract system following the vendor’s
mented with 5 mM glutathione (reduced form). The peakinstruction (Promega).
fractions were analyzed on SDS–PAGE followed by
Western blots.Immunoprecipitations
All centrifugation steps were carried out at 6000 rpm
RESULTSfor 2 min in an Eppendorf table-top centrifuge Model
5415C. Antibodies were coupled to protein A/G–agarose Reactivity of MAbs with E1 and E2
(Jackson Immunochemicals) overnight at 47 (10 ml of a
We used the baculovirus-derived expression system50% suspension of protein A/G–agarose and 250 ml of
for high-level synthesis of the HPV-33 encoded E1 andhybridoma cell supernatant) and subsequently washed
E2 proteins. Both E1 and E2 are nuclear proteins andtwice with buffer D (20 mM Tris–HCl, 250 mM NaCl,
were efficiently extracted from isolated nuclei of Sf9 in-0.125% Triton X-100, 1 mM EDTA, 10% glycerol, 1 mM
sect cells using 300 mM NaCl. In SDS–PAGE analysisDTT, pH 7.5). Nuclear extracts were diluted 1:2 with buffer
both E1 and E2 migrate somewhat slower than expectedC (20 mM Tris–HCl, 200 mM NaCl, 2 mM EDTA, 10%
(85 kDa vs 72.4 kDa expected for E1 and 43 kDa vs 40.2glycerol, 1 mM DTT, pH 7.5). Five hundred microliters
kDa for E2). The E2 protein tends to aggregate in theeach of E1- and E2-containing extracts was added to the
presence of SDS, sometimes resulting in high-molecular-protein A/G–sepharose–antibody complex (final volume,
weight forms in SDS–PAGE analysis. To monitor expres-1 ml). The volume was adjusted to 1 ml with buffer D
sion of E1 and E2, MAbs were raised against denaturedwhen only one of the extracts was used. The mixture
GST-E1 and -E2 fusion proteins, respectively. The MAbswas incubated for 12 hr (47) using a rotator. The agarose
33E1-C1A and 33E2-Ste3 obtained were specific for E1was collected by centrifugation and washed three times
and E2 in enzyme-linked immunosorbent assays, respec-with buffer D (500 ml each). When indicated, new nuclear
tively, and were also reactive in immunoblots. As shownextract was added, incubated again overnight, and
in Fig. 1A (lane 1) and Fig. 1B (lane 2) for MAb 33E1-C1Awashed three times with buffer D. Following the last
and MAb 33E2-Ste3, respectively, the antibodies alsowash the supernatant was completely removed, and the
reacted with the corresponding full-length proteins ex-pellet was resuspended in 20 ml sample buffer (2.51),
tracted from insect cells. No cross-reactivity with otherand subsequently boiled for 10 min. The samples were
proteins was observed (Fig. 1A, lane 2; Fig. 1B, lane 1).then analyzed on a SDS–PAGE followed by a Western
To test the specificity of the MAbs in immunoprecipita-blot (Towbin et al., 1979) using MAbs 33E1-C1A and
tions, E1- and E2-containing crude nuclear extracts were33E2-Ste3 to detect E1 and E2 protein, respectively. Im-
incubated with antibodies previously bound to protein A/mune complexes were visualized using rabbit anti-
G–agarose beads. The proteins that bound to themouse IgG-horseradish peroxidase (Jackson Immuno-
washed beads were then analyzed in immunoblots. Un-chemicals) and enhanced chemiluminescence (Amer-
der these conditions, the high specificity of MAb 33E1-sham).
C1A for E1 (Fig. 1A, lane 3; Fig. 1B, lane 11) and of MAbWhen in vitro translated E1 proteins were used for
33E2-Ste3 for E2 (Fig. 1B, lane 4; Fig. 1A, lane 12) wasimmunoprecipitation, E2 protein purified from insect cells
completely retained. Both MAbs immunoprecipitate theirwas coupled to protein A/G–agarose beads carrying
cognate antigen very efficiently (more than 80% of inputMAb 33E2-Ste3 at 47 overnight. The washed beads were
protein), indicating that they recognize the authentic pro-added to 500 ml of the precleared (2 min, 14000 rpm) in
teins, not a denatured subfraction. E1 protein is foundvitro translation mixture diluted in buffer B (1:100), incu-
as a monomer as well as an oligomer in nuclear extracts.bated for 12 hr (47) or 3 hr (227), and washed with buffer
Both forms are immunoprecipitated by MAb 33E1-C1AB. Proteins were eluted with sample buffer and analyzed
(data not shown).by SDS–PAGE and autoradiography.
Competition of MAb 33E1-C1A and E2Affinity chromatography
for binding to E1
One milliliter of glutathione–Sepharose was equili-
brated in PBS, added to E. coli extracts prepared from a In initial experiments to study the interaction between
E1 and E2, E2 protein from crude nuclear extracts was500-ml culture as suggested by the vendor (Pharmacia),
and incubated in a batch overnight at 47. The beads bound to agarose via MAb 33E2-Ste3 and incubated with
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used (lane 7). When E1- and E2-containing nuclear ex-
tracts and MAb 33E1-C1A were mixed simultaneously,
the amount of E1 detected in the pellet was significantly
reduced. Again, no E2 protein was immunoprecipitated
(lane 9). Under these conditions, MAb 33E2-Ste3 very
efficiently immunoprecipitated both E1 and E2 as ob-
served before (lane 10). These results strongly suggest
that E2 and MAb 33E1-C1A compete for the same binding
site on the E1 protein. Since preformation of the E1/E2
complex totally prevents binding of MAb 33E1-C1A to E1,
all of the E1 protein present must be in a complex with
E2, indicating that the complex formation is very efficient
under our conditions at 47. E2 protein bound to mono-
meric as well as oligomeric E1 (data not shown).
Epitope mapping of MAb 33E1-C1A
As a first step to identify the E2 binding domain of E1
FIG. 1. MAb 33E1-C1A and E2 compete for binding to E1. Immunopre- we mapped the epitope of MAb 33E1-C1A. Since MAb
cipitations at 47 of HPV-33-encoded E1 and E2 proteins from nuclear 33E1-C1A had been raised against a GST fusion protein
extracts of insect cells infected with bac33E1 and bac33E2, respec- containing E1 amino acids 441 to 641, deletions were
tively, using MAb 33E1-C1A (lanes 3, 5, 7, 9, and 11) and 33E2-Ste3
introduced into the GST fusion protein using PCR-di-(lanes 4, 6, 8, 10, and 12). Immunoprecipitates were analyzed by West-
rected mutagenesis with pG33E1-441/641 as template.ern blots using MAbs 33E1-C1A (A) and 33E2-Ste3 (B) as primary anti-
bodies. Lane 1, E1-containing nuclear extract; lane 2, E2-containing Mutant proteins were expressed as GST fusion proteins
nuclear extract; lanes 3 and 4, immunoprecipitates from E1 (lane 3)- in E. coli and probed with MAb 33E1-C1A in immunoblots
and E2-containing (lane 4) nuclear extracts; lanes 5 and 6, immunopre- (Fig. 2B). The amount of fusion protein loaded onto the
cipitates of E1 and E2 prebound to agarose via their corresponding
gel was normalized using a MAb (GST-A) directedantibody overnight and subsequently incubated with E2- and E1-con-
against the GST portion (Fig. 2A). The GST protein itselftaining extracts for 12 hr, respectively; lanes 7 and 8, immunoprecipi-
tates from preformed E1 and E2 complexes obtained by mixing nuclear was not stained with MAb 33E1-C1A (Fig. 2B, lane 1).
extracts for 3 hr at 47; lanes 9 and 10, immunoprecipitates from E1- Removal of C-terminal sequences up to amino acid 600
and E2-containing nuclear extracts mixed immediately before the addi-
tion of the agarose-bound antibody; lanes 11 and 12, controls; immuno-
precipitates from E2 (lane 11)- and E1-containing (lane 12) nuclear
extracts. Numbers to the left indicate the molecular weight of marker
proteins in kilodaltons. H and L indicate the positions of heavy and
light chains of IgG, respectively. The positions of E1 and E2 are shown
to the right.
E1-containing nuclear extracts. We have calculated from
Western blot analyses that a slight excess of E2 protein
over E1 was used in this and the following immunopre-
cipitations (approximately twofold). Under these condi-
tions a significant portion of the E1 protein interacted
with E2 and could be recovered from the agarose beads
together with E2 (Figs. 1A and 1B, lane 6). Both mono-
meric and oligomeric E1 protein was able to form com-
plexes with E2 (data not shown). Similar results were
obtained when complexes of E1 and E2 were previously
formed by preincubating the two nuclear extracts for 3 hr
and subsequently immunoprecipitated using MAb 33E2-
Ste3 (lane 8). However, E1 coupled to agarose beads
via MAb 33E1-C1A failed to retain E2 protein from E2-
FIG. 2. Epitope mapping of MAb 33E1-C1A. Western blot of GSTcontaining extracts, indicating that E2 protein cannot
(lane 1) and GST-E1 fusion proteins G33E1-441/641 (lane 2), -567/641bind to the E1–antibody complex. Only E1 protein was
(lane 3), -567/600 (lane 4), -567/589 (lane 5), -584/600 (lane 6), and
found in the immunoprecipitates (lane 5). To our surprise, -589/600 (lane 7) reacted with MAb GST-A (A) or MAb 33E1-C1A (B).
MAb 33E1-C1A completely failed to immunoprecipitate Numbers to the left indicate the molecular weight of marker proteins
in kilodaltons.both E1 and E2 when preformed E1/E2 complexes were
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largest N-terminal deletion analyzed starting at E1 amino
acid 312 showed the strongest binding. In the absence of
E2 proteins none of the E1 mutants bound to the agarose
beads (data not shown). Since we had observed that
removal of N-terminal sequences of E1 increased the
interaction with E2 significantly using this assay system,
we also tested mutants carrying both N-terminal and C-
terminal deletions. Again, none of these mutant proteins,
including 33E1-75/450, -312/450, -75/520 and -312/520,
interacted with E2 at 47 (Fig. 3B; lanes 4, 5, 7, and 8).
Interaction of E2 with E1 deletion mutants
fused to GST
In the second assay used to analyze the E1/E2 interac-
tion GST-E1 fusion proteins were expressed in E. coli
and bound to glutathione–Sepharose. After extensive
washing to remove contaminating proteins, E2-con-
taining nuclear extracts from Sf9 cells were loaded ontoFIG. 3. Interaction of E2 with E1 mutant proteins translated in vitro
at 47. (B) SDS–PAGE analysis of in vitro translated E1 proteins 33E1- the Sepharose columns at 47. The bound proteins were
75/644 (lane 1), -312/644 (lane 2), -1/450 (lane 3), -75/450 (lane 4), eluted with glutathione and were analyzed using MAb
-312/450 (lane 5), -1/520 (lane 6), -75/520 (lane 7), and -312/520 (lane GST-A (Fig. 4A) and MAb 33E2-Ste3 (Fig. 4B). As can be8) immunoprecipitated with MAb 33E2-Ste3 in the presence of insect
seen in Fig. 4A, all fusion proteins were substantiallycell expressed E2 protein. (A) Input protein. Numbers to the left indicate
degraded. To compensate for the degradation thethe molecular weight of marker proteins in kilodaltons. Autoradiographs
are shown. amounts of protein loaded on the various slots of the gel
in Fig. 4B were adjusted to contain similar amounts of
the undegraded fusion proteins. As shown in Fig. 4B, all
was still recognized by MAb 33E1-C1A (lanes 2 to 4). N- N-terminal deletions tested (G33E1-1/644, -75/644, -150/
terminal portions could be deleted up to amino acid 584 644, and -312/644 (lanes 2 to 5)) bound significant
without affecting the reactivity with the antibody (lane 6).
We were thus able to pinpoint the epitope to E1 amino
acids 584 to 600. Further N- or C-terminal deletions re-
sulted in a loss of reactivity with MAb 33E1-C1A (lanes
5 and 7).
Interaction of E2 with in vitro translated E1 deletion
mutants
To verify that the C-terminal portion of E1 is indeed
responsible for the binding to E2, the interaction of E2
with E1 deletion mutants was assayed using two different
systems: (i) coimmunoprecipitation of in vitro translated
E1 deletion mutants with E2 extracted from insect cells
using MAb 33E2-Ste3 and (ii) incubation of the E2 protein
with E1 deletions fused to GST and coupled to glutathi-
one–Sepharose beads. The mutants constructed by
PCR-directed mutagenesis are depicted in Fig. 8.
In the first assay, approximately equal amounts of the
mutant E1 protein translated in vitro using the rabbit retic-
FIG. 4. Interaction of E2 protein with bacterially expressed GST-E1
ulocyte lysate system (Fig. 3A) were added to preformed fusion proteins at 47. GST (lane 1) and GST-E1 fusion proteins G33E1-
MAb 33E2-Ste3/E2 complexes coupled to agarose beads 1/644 (lane 2), -75/644 (lane 3), -150/644 (lane 4), -312/644 (lane 5),
-1/520 (lane 6), and -1/450 (lane 7) were bound to glutathione–Sepha-at 47. As shown in Fig. 3B, N-terminal deletions having
rose and subsequently incubated for 12 hr with E2-containing nuclearan intact C-terminus, including 33E1-75/644 and -312/
extracts. Bound proteins were eluted with glutathione and analyzed in644, were able to bind to E2 (lanes 1 and 2). 33E1-150/
Western blots for the presence of GST fusion protein using MAb GST-
644 was not stable after translation and was therefore A (A) and for E2 protein using MAb 33E2-Ste3 (B). Molecular size
not tested. In contrast, the C-terminal deletions tested markers (in kilodaltons) are shown to the left. Undegraded GST fusion
proteins are highlighted by white circles.were not coprecipitated with E2 (lanes 3 and 6). The
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teins G33E1-1/644-P586E and -75/644-P586E. As men-
tioned above, this mutation results in the loss of reactivity
with MAb 33E1-C1A (Fig. 6B). Similarly, E2 protein did
not bind to these proteins immobilized on glutathione–
Sepharose (Fig. 6C, lanes 3 and 5), whereas good bind-
ing was again observed for G33E1-1/644 and -75/644
(lanes 2 and 4). MAb GST-A was again used to adjust
the level of nondegraded GST-E1 fusion proteins (Fig.
6A). We therefore conclude that the E1 amino acid 586
may play an important role in the interaction with the E2
protein at 47.
Interaction between E1 and E2 at 227
It was recently reported that the interaction between
BPV-1 E1 and E2 at higher temperatures is mediated
via an N-terminal E1 domain rather than the C-terminus
(Thorner et al., 1993; Benson and Howley, 1995). We
therefore tested the interaction of HPV-33 E1 and E2 at
room temperature using GST-E1 mutants and wild-type
E2 protein expressed in insect cells. G33E1-1/644 and
FIG. 5. Interaction of E2 with E1 point mutants at 47. (A) Input proteins.
-312/644 retain their ability to bind E2 at 227 (Fig. 7, lanes(B) In vitro translated E1 proteins 33E1-1/644 (lane 1), -1/644-P586E
2 and 3), as did G33E1-75/644 (data not shown). G33E1-(lane 2), -75/644 (lane 3), -75/644-P586E (lane 4), -312/644 (lane 5),
and -312/644-P586E (lane 6) were immunoprecipitated with MAb 33E2- 1/520, -1/450, and -75/520, to which E2 protein did not
Ste3 in the presence of E2 extracted from insect cells. Numbers to the bind at 47, were now able to associate with E2 (lanes
left indicate the molecular weight of marker proteins in kilodaltons. 4 to 6). To more precisely locate this binding domain,
Autoradiographs of SDS–PAGEs are shown.
additional GST-33E1 deletion mutants comprising E1
amino acids 312 to 520, 312 to 450, 312 to 420, 312 to
375, 1 to 358, and 1 to 206, respectively, were con-amounts of E2 protein. No E2 protein was detected in
structed. G33E1-312/520 and -312/450 efficiently boundeluates from columns loaded with GST protein (lane 1)
E2 protein (Fig. 7, lanes 7 and 8), whereas G33E1-312/or the C-terminal deletion mutants G33E1-1/450 and -1/
420, -312/375, -1/358, and -1/206 had no binding activity520 (lanes 6 and 7). We conclude from these data that
at all (Fig. 7, lanes 9 to 12). Identical results were ob-the C-terminal sequence encompassing E1 amino acids
tained using in vitro translation of E1 deletion mutants312 to 644 is sufficient for interaction with the E2 protein
33E1-75/644, -312/644, -1/520, and -1/450 (data notat 47.
shown). We conclude from these data that HPV-33 E1
amino acids 312 to 450 are sufficient for an efficientPoint mutation in the E2 binding domain
binding to the E2 protein at 227.
In a further step to pinpoint the E1 region responsible We were then interested whether the C-terminal do-
for the interaction with E2 the proline residue at position main is still active at 227 in the context of full-length
586 in the E1 protein was changed to glutamic acid. This E1 protein. To this end, the preformed wild-type E1/E2
mutation results in the loss of reactivity with MAb 33E1- complex obtained in insect cell extracts was used for
C1A in both Western blot analysis (see Fig. 6B) and im- immunoprecipitations at 227. MAb 33E1-C1A was still not
munoprecipitation (data not shown). The point mutation able to bind to the E1/E2 complex, whereas MAb 33E2-
was introduced into the context of full-length as well as Ste3 immunoprecipitated the complex efficiently, exactly
N-terminally shortened E1 proteins. The mutant proteins as previously observed at 47. Both MAbs bound their
were then tested for their ability to bind E2 protein using corresponding uncomplexed antigen efficiently under
in vitro translated E1 and GST-E1 fusion proteins. Care these conditions (data not shown). This strongly sug-
was taken to use similar amounts of in vitro translated gests that the C-terminal domain is still interacting with
proteins (Fig. 5A). Introduction of the mutation resulted E2 at 227.
in a significant reduction of E2 binding activity of more
than 75% using in vitro translated 33E1-1/644-P586E, -75/ DISCUSSION
644-P586E, and -312/644-P586E under conditions where
good binding of the wild-type proteins was observed (Fig. We have shown that the E1 and E2 proteins of HPV-
33 synthesized in insect cells using recombinant bacu-5B, lanes 1 to 6). Control experiments without E2 proved
again the specificity of the binding (data not shown). loviruses form a complex in solution. Coimmunoprecipi-
tation analyses indicate that the interaction of E1 and E2These results were confirmed using GST fusion pro-
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FIG. 6. Interaction at 47 of E2 with GST-E1 fusion proteins carrying a point mutation. Glutathione–Sepharose columns were loaded with GST
(lane 1), G33E1-1/644 (lane 2), -1/644-P586E (lane 3), -75/644 (lane 4), and -75/644-P586E (lane 5) and subsequently with E2-containing extracts.
The eluates were analyzed in Western blots using MAbs GST-A (A), 33E1-C1A (B), and 33E2-Ste3 (C). Molecular size markers are shown to the
left.
is very efficient at 47. Making use of MAb 33E1-C1A, E2. One domain active at low temperature (47) was
mapped to the C-terminal 332 amino acids of E1 (aminowhich competes with E2 for binding to E1, we were able
to demonstrate that all of the E1 protein present in nu- acids 312–644). Removal of additional N-terminal se-
quences up to amino acid 441 and 460, respectively,clear extracts interacts with E2. Both monomeric and
oligomeric E1 found in nuclear extracts was able to bind destroyed the E2 binding activity (data not shown). Since
the inhibiting MAb 33E1-C1A binds to E1 amino acidsto E2. The domain of E1 involved in the interaction with
E2 should therefore be exposed on E1 oligomers. Consis- 584–600 this peptide is involved in the interaction with
E2. These results were confirmed by the introduction of atent with these data, MAb 33E1-C1A was able to immuno-
precipitate monomeric and oligomeric forms of the E1 point mutation at the position of amino acid 586 (Pro r
Glu) resulting in the loss of binding of both MAb 33E1-protein, indicating that its binding site is also exposed
on the surface of oligomeric E1. C1A and E2. The importance of the C-terminus spanning
from amino acids 520 to 644 is further emphasized byA deletion mutagenesis was carried out to map E1
domains involved in the binding to E2. The results are the failure of the C-terminal deletion mutatants G33E1-
1/520 and -1/450 to bind E2. Taken together these resultssummarized in Fig. 8. We have identified two regions of
the E1 protein of HPV-33 that are able to interact with clearly demonstrate that the C-terminal region of E1 is
absolutely required for the interaction with E2 at 47. Our
results are similar to those obtained in a detailed muta-
genesis study of the BPV-1 E1 protein, also demonstra-
ting that the C-terminus of E1 is required for interaction
with E2 (Lusky and Fontane, 1991).
An additional domain of the E1 protein became active
in E2 binding, when the assay temperature was raised
to 227. Now the C-terminus, including the MAb 33E1-
C1A binding site, was dispensable for E2 binding. The
additional domain was mapped to amino acids 312 to
450. Since MAb 33E1-C1A and the E2 protein still com-
peted for the same binding site on the E1 protein at 227
as evidenced by the inability of the MAb to precipitate
the preformed E1/E2 complex, the C-terminal domain
must be active in binding to E2 at the elevated tempera-
ture.
There is currently some uncertainty concerning the
domain(s) of E1 involved in complex formation with E2.
FIG. 7. Interaction of E2 with GST-E1 fusion proteins at 227. Glutathi-
Apparently contradicting results have been reported.one–Sepharose columns were loaded with GST (lane 1), G33E1-1/644
Thorner et al. (1993) found that interaction at 47 was(lane 2), -312/644 (lane 3), -1/520 (lane 4), -1/450 (lane 5), -75/520 (lane
6), -312/520 (lane 7), -312/450 (lane 8), -312/420 (lane 9), -312/375 (lane mediated by amino acids 458 to 605 (corresponding to
10), -1/358 (lane 11), and -1/206 (lane 12) and subsequently incubated HPV-33 amino acids 495 to 644), whereas a shift to more
at 227 for 3 hr with E2-containing nuclear extracts. The eluates were N-terminally located regions was observed at elevated
analyzed in Western blots for GST-E1 fusion proteins using MAb GST-
temperatures. A polypeptide encompassing the first 423A (A) and E2 using MAb 33E2-Ste3 (B). Undegraded GST fusion proteins
amino acids contained all the information sufficient forare highlighted by white circles. Molecular size markers are shown to
the left. (i) interaction with E2, (ii) DNA binding, and (iii) displaying
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FIG. 8. Schematic representation of the results obtained. HPV-33 E1 deletion mutants are indicated by horizontal bars. The numbers to the left
indicate the first and last E1 amino acids present in the deletion mutants. Binding of E2 to E1 mutants translated in vitro (in vitro) or expressed as
GST fusion proteins (GST) at two different temperatures is shown to the right. /, binding; 0, no binding; nt, not tested; ns, not stable.
cooperativity of DNA binding in the presence of E2 and mutants described in this communication. This will help
to better understand the functional aspects of the E1/the weak E2 binding site 12. Recently, interaction be-
tween E1 and E2 of BPV-1 was mapped to amino acids E2 interaction and to clarify the observed differences
between HPV and BPV replication.1 to 250 in vitro at 227 and in vivo using the yeast two-
hybrid system (Benson and Howley, 1995). Our results
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